• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Clovis Oncology Inc

+ Add to Watchlist


56.6400 USD 1.0400 1.80%

As of 20:10:00 ET on 12/19/2014.

Snapshot for Clovis Oncology Inc (CLVS)

Open: 57.5400 Day's Range: 56.4200 - 58.7100 Volume: 1,138,826
Previous Close: 57.6800 52wk Range: 35.3300 - 93.3300 1-Yr Rtn: +0.48%

Stock Chart for CLVS

No chart data available.
  • CLVS:US 56.4499
  • 1D
  • 1M
  • 1Y
Interactive CLVS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CLVS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -3.8282
Est. EPS (USD) (12/2014) -4.2390
Est. PEG Ratio -
Market Cap (M USD) 1,923.75
Shares Outstanding (M) 33.96
30 Day Average Volume 746,409
Price/Book (mrq) 4.9544
Price/Sale (ttm) 140.5919
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CLVS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CLVS

Clovis Oncology Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. Clovis target its development programs for the treatment of specific subsets of cancer populations.

Patrick J MahaffyPresident/CEO/Co-FounderErle T MastExec VP/CFO/Secy/Co-Founder
Andrew R AllenExec VP/Chief Medical OfcrSteven L HoerterSenior VP:Commercial
More Company Profile & Key Executives for CLVS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil